Anti-Serum Amyloid A Antibody [132]

Produced as a mouse monoclonal of the IgG3 isotype, this unconjugated primary antibody from Antibodies.com targets human Serum Amyloid A (SAA), an acute-phase protein expressed by hepatocytes during systemic inflammation. The reagent carries clone designation 132 and is supplied lyophilised at 100 µg per vial so it can be reconstituted in the user's laboratory and dispensed into aliquots sized for their workflow.

Validated for ELISA and intended for in vitro research use on human samples, the antibody supports studies of acute-phase responses, infection, atherosclerosis, autoimmune disease, and other conditions in which circulating SAA concentrations are tracked as a biomarker. With no fluorophore, biotin, or enzyme reporter attached, investigators can conjugate the antibody themselves to HRP, streptavidin, a fluorescent dye, or any other label suited to their chosen detection method.

The lyophilised format keeps the antibody stable under standard refrigerated storage until reconstitution, after which it is typically handled at 4 °C and protected from repeated freeze-thaw cycles to preserve binding activity. Defined specificity for human SAA, together with the consistency of a monoclonal reagent, makes this clone 132 antibody a practical choice for laboratories building ELISA-based acute-phase biomarker panels.